Telix Pharmaceuticals (TLX.AX) Earnings Analysis
Telix Pharmaceuticals (TLX.AX) next reports earnings on 2026-08-20, consensus EPS 0.05531 AUD. Last quarter (2026-02-19) it missed with EPS -0.01738 AUD vs 0.04911 AUD est (-135.4%). It has beaten estimates in 0/4 recent quarters (0%). Trailing P/E -472.59.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does TLX.AX next report earnings?
| Next earnings date | 2026-08-20 |
|---|---|
| Consensus EPS estimate | 0.05531 AUD |
| Revenue estimate | 0.69B |
TLX.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-19 | -0.01738 AUD | 0.04911 AUD | -135.4% | Miss |
| 2025-08-20 | -0.01033 AUD | 0.203 AUD | -105.1% | Miss |
| 2025-02-20 | 0.1108 AUD | 0.1462 AUD | -24.2% | Miss |
| 2024-08-22 | 0.0333 AUD | 0.13 AUD | -74.4% | Miss |
Beat rate: 0/4 (0%) over reported quarters with consensus data.
TLX.AX valuation and analyst view
| Trailing P/E | -472.59 |
|---|---|
| Trailing EPS | -0.03205 AUD |
| Price / book | 8.25 |
| Dividend yield | 0.00% |
| Market cap | 5.03B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Telix Pharmaceuticals (TLX.AX)'s next earnings date?
Telix Pharmaceuticals is next scheduled to report on 2026-08-20, with a consensus EPS estimate of 0.05531 AUD and revenue estimate of 0.69B.
Did TLX.AX beat earnings last quarter?
In its 2026-02-19 report, TLX.AX posted EPS of -0.01738 AUD versus a 0.04911 AUD estimate — a miss of 135.4%.
What is TLX.AX's earnings track record?
Over the last 4 reported quarters with consensus data, TLX.AX beat estimates 0 times (0%).
What is TLX.AX's current P/E ratio and EPS?
TLX.AX trades at a trailing P/E of -472.59 on trailing EPS of -0.03205082384334284 AUD.
What do analysts rate TLX.AX?
TLX.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.